by Xcellerant Ventures | May 11, 2023 | Portfolio Company News
Orgionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-new-test-that-can-identify-those-in-most-danger-from-covid-19-301821712.html PHOENIX, May 11, 2023 /PRNewswire/ — Tesis Biosciences, the leader in targeted genetic...
by Xcellerant Ventures | Apr 20, 2023 | Portfolio Company News
Content origionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-a-novel-pharmacogenomics-test-enabling-precise-personalized-response-to-wide-range-of-pharmaceuticals-301802763.html PHOENIX, April 20, 2023 /PRNewswire/...
by Xcellerant Ventures | Dec 9, 2022 | Portfolio Company News
Content origionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-proposed-study-of-veterans-and-civilians-with-mild-traumatic-brain-injury-301698945.html PHOENIX, Dec. 9, 2022 /PRNewswire/ — Tesis Biosciences, the leader...
by Xcellerant Ventures | Feb 16, 2022 | Portfolio Company News
Content origionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-acquires-genome-explorations-to-accelerate-clinical-research-and-product-development-for-chronic-disease-cures-301483118.html PHOENIX and MEMPHIS, Tenn., Feb. 16,...
by Xcellerant Ventures | Oct 13, 2021 | Portfolio Company News
Content origionally from PR News wire: https://www.prnewswire.com/news-releases/john-shufeldt-md-joins-tesis-labs-board-of-directors-301398790.html PHOENIX, Oct. 13, 2021 /PRNewswire/ — Tesis Labs, a leader in targeted genetic sequencing, announced today the...
